Cipla unit gets notice from US firm for termination of acquisition deal

In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business firm Avenue Therapeutics for up to USD 215 million (around Rs 1,560 crore).

from Moneycontrol Business News https://ift.tt/3BMCi0g